If you bought XBI a year ago and held it, you are up roughly 65%. If you bought Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA:LABU) on the same day, you are up about 235%. That is the pitch for ...
The coronavirus pandemic is fueling gains for biotechnology exchange traded funds this year and the leverage members of this group are participating in the fun. “Despite its growth image, the ...
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have ...
The Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) offers 3x daily leveraged exposure to the S&P Biotechnology Select Industry Index. LABU is highly liquid and popular among short-term traders, ...
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3X Shares (Symbol: LABU) where we have ...
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3x Shares is trading at $285.63 per share. Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3x Shares total debt is unavailable.
Summary Seeking Alpha Quant rates LABU as a Buy. I rate it as a Strong Buy because the underlying index is bullish. The recent decline in interest rates have led to better access to investing capital ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Hosted on MSN
LABU: Direxion Daily S&P Biotech Bull 3X ETF
The Direxion Daily S&P Biotech Bull 3X Fund (NYSEARCA: LABU) is an exchange traded fund (ETF) that seeks to replicate 300% of the daily performance (before fees and expenses) of its underlying index, ...
Direxion Daily S&P Biotech Bull 3X Shares (LABU) delivered 235% returns over the past year versus 65% for the underlying XBI biotech ETF by leveraging daily gains, but the fund is down 87% over five ...
Sean Ross is a strategic adviser at 1031x.com, Investopedia contributor, and the founder and manager of Free Lances Ltd. The Direxion Daily S&P Biotech Bull 3X Fund (NYSEARCA: LABU) is an exchange ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results